Recent studies have shown that increased activation of ACE2/Ang-(1–7)/MasR axis can revert and prevent local and systemic dysfunctions improving lipid profile and insulin resistance by modulating insulin actions, and reducing inflammation [32,33]. This evidence concerns the gene MAS1L and Insulin resistance.